Qiagen NV (QGEN) Company Profile & Statistics

Qiagen NV
QGEN
(NYSE)
Closed
39.47
+0.24 (+0.61%)
in:usd•As of: Apr 18, 2024 15:59 UTC -4
Open
39.28
High
39.55
Low
39.06

About Qiagen NV

CEO

Thierry Bernard

Headquarters

hulsterweg 82

pl venlo, p7 5912, netherlands

Auditor

KPMG AG Wirtschaftspr¿fungsgesellschaft

Employees

5,967

Share Holders

Website

www.qiagen.com

Industry

medical specialties

Sector

health technology

Company Overview

QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.

Qiagen NV Statistics

Valuation Measures

Market Capitalization ²	9.01B
Enterprise Value	9.85B
Enterprise Value/EBITDA (ttm)	15.26
Price to Earnings Ratio (ttm)	18.57
Price to Book (mrq)	2.36
Price to Sales (ttm)	4.57
Price to Cash (ytd)	12.60

Profitability

Gross Margin (ttm)	62.78%
Operating Margin (ttm)	24.26%
Profit Margin (ttm)	17.34%
Return on Equity (ttm)	12.99%
Return on Invested Capital (ttm)	6.89%
Return on Assets (ttm)	7.74%

Income Statement

Revenue (ttm)	1.97B
Revenue Per Share (ttm)	8.61
Gross Profit (ttm)	1.23B
EBITDA (ttm)³	645.44M
Net Income Avi to Common (ttm)	341.30M
Diluted EPS (ttm)	1.51

Share Statistics

Beta (5Y Monthly)	0.41
52-Week Change	-13.89%
S&P500 52-Week Change	20.61%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	228.20M
Dividend Yield	0.00%
Float ⁴	207.66M
% Held by Insiders	9.00%
% Held by Institutions	70.00%

Balance Sheet

Total Cash (mrq)	1.06B
Total Cash Per Share (mrq)	4.64
Total Debt (mrq)	1.51B
Total Debt/Equity (mrq)	39.65%
Current Ratio (mrq)	1.99%
Quick Ratio (mrq)	1.62%
Book Value Per Share (mrq)	16.69

Cash Flow

Operating Cash Flow Per Share (ytd)	1.99
Free Cash Flow (ytd)	309.75M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Qiagen NV

Trade With A Regulated Broker